Kevin Broadfin Healthcare M... Net Worth

The estimated Net Worth of Kevin Broadfin Healthcare M... is at least 28.8 百万$ dollars as of 19 November 2021. Kevin M owns over 100,000 units of Biodelivery Sciences International stock worth over 28,835,954$ and over the last 6 years Kevin sold BDSI stock worth over 0$.

Kevin M BDSI stock SEC Form 4 insiders trading

Kevin has made over 2 trades of the Biodelivery Sciences International stock since 2018, according to the Form 4 filled with the SEC. Most recently Kevin bought 100,000 units of BDSI stock worth 306,000$ on 19 November 2021.

The largest trade Kevin's ever made was buying 100,000 units of Biodelivery Sciences International stock on 19 November 2021 worth over 306,000$. On average, Kevin trades about 34,375 units every 398 days since 2018. As of 19 November 2021 Kevin still owns at least 5,158,489 units of Biodelivery Sciences International stock.

You can see the complete history of Kevin M stock trades at the bottom of the page.

What's Kevin M's mailing address?

Kevin's mailing address filed with the SEC is 300 Park Ave, New York, NY 10022, USA.

Insiders trading at Biodelivery Sciences International

Over the last 21 years, insiders at Biodelivery Sciences International have traded over 111,671,776$ worth of Biodelivery Sciences International stock and bought 1,813,177 units worth 5,352,510$ . The most active insiders traders include International, L.P. Elliott、Associates, L.P. Elliott、Healthcare Master Fund Ltd .... On average, Biodelivery Sciences International executives and independent directors trade stock every 18 days with the average trade being worth of 420,648$. The most recent stock trade was executed by Jeffrey Allen Bailey on 9 March 2022, trading 5,333 units of BDSI stock currently worth 29,811$.

What does Biodelivery Sciences International do?

BioDelivery Sciences International, Inc. is a commercial-stage specialty pharmaceutical company dedicated to patients living with chronic conditions. BDSI has built a portfolio of products that includes utilizing its novel and proprietary BioErodible MucoAdhesive (BEMA®) technology to develop and commercialize, either on its own or in partnership with third parties, new applications of proven therapies aimed at addressing important unmet medical needs. BDSI's marketed products address serious and debilitating conditions, including chronic pain and opioid-induced constipation.

Complete history of Kevin M stock trades at Biodelivery Sciences International

Biodelivery Sciences International executives and stock owners

Biodelivery Sciences International executives and other stock owners filed with the SEC include:

• Scott Plesha,
  President, Chief Commercial Officer
• Mary Coelho,
  Chief Financial Officer, Treasurer
• Thomas Smith,
  Chief Medical Officer
• James Vollins,
  Chief Compliance Officer, General Counsel, Corporate Secretary
• Scott M. Plesha,
  Pres & Chief Commercial Officer
• James Vollins J.D.,
  Gen. Counsel, Chief Compliance Officer & Corp. Sec.
• Dr. Thomas B. Smith FAAFP, M.D.,
  Chief Medical Officer
• Vanila Singh,
  Independent Director
• Mark Sirgo,
  Vice Chairman of the Board
• Todd Davis,
  Independent Director
• Peter Greenleaf,
  Independent Chairman of the Board
• William Watson,
  Independent Director
• Kevin Kotler,
  Independent Director
• Kevin Ostrander,
  Senior Vice President - Business Development
• Joseph Lockhart,
  Senior Vice President - Operations
• Jeffrey Bailey,
  Chief Executive Officer
• Dr. Jeff Katz,
  Member of Scientific Advisory Board and Member of Arius Scientific Advisory Board
• Dr. Arthur G. Lipman PharmD,
  Member of Scientific Advisory Board and Member of Arius Scientific Advisory Board
• Dr. Bill McCarberg,
  Member of Scientific Advisory Board and Member of Arius Scientific Advisory Board
• John Golubieski,
  CFO & Chief Accounting Officer
• Niraj Vasisht,
  Chief Technology Officer
• Samuel P Jr Sears,
  Director
• Barry I Feinberg,
  Director
• Charles Bramlage,
  Director
• William B Stone,
  Director
• Francis E Jr Odonnell,
  Director
• Thomas D'alonzo,
  Director
• Healthcare Master Fund Ltd ...,
  
• Timothy Tyson,
  Director
• W. Mark Watson,
  Director
• Kevin Broadfin Healthcare M...,
  
• Herm Cukier,
  Chief Executive Officer
• John J Shea,
  Director
• Iv Llc Ramsay David Russ Le...,
  
• Capital Group Ii Llc Hopkins,
  10% owner
• Allan Pearce,
  Director
• James R Butler,
  Director
• Paolantonio Ernest Robert De,
  CFO and Secretary
• Associates, L.P. Elliott,
  10% owner
• James A Mcnulty,
  Chief Financial Officer
• William Poole,
  Director
• Kathleen M Tr Irrev Tr 1 Fb...,
  10% owner
• Raphael J Mannino,
  Executive Vice President & CSO
• Donald Ferguson,
  Director
• Iv Llccdc Operations Llc Ra...,
  
• International, L.P. Elliott,
  10% owner
• L M Stephenson,
  Director
• Capital Group Llc Hopkins,
  10% owner
• Kathleen M O Donnell,
  10% owner
• Benny Ward,
  EVP of Busi. & Strategic Dev.
• John Golubieski,
  See Remarks